Search


 
Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 17 (Search time: 0.001 seconds).
Item hits:
First PublishedTitleAuthor(s)Type
9-Nov-2018Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocoHussein, H; Zaccardi, F; Dhalwani, N; Davies, M; Khunti, K; Gray, LJournal Article
6-Dec-2018Intensive versus standard multifactorial cardiovascular risk factor control in screen-detected type 2 diabetes: 5 year and longer-term modelled outcomes of the ADDITION-Leicester studyWebb, D; Dales, J; Zaccardi, F; Hill, S; Moore, C; Farooqi, A; Griffin, S; Davies, M; Khunti, KJournal Article
19-Nov-2018Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis.Vetrone, LM; Zaccardi, F; Webb, DR; Seidu, S; Gholap, NN; Pitocco, D; Davies, MJ; Khunti, KJournal Article
17-Jan-2019Cardiovascular efficacy and safety of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a systematic review and network meta-analysisHussein, H; Zaccardi, F; Khunti, K; Seidu, S; Davies, MJ; Gray, LJJournal Article
15-Feb-2019Selectivity of beta-blockers, cardiovascular and all-cause mortality in people with hypoglycaemia: an observational studyDavies, M; Zaccardi, F; Nystrup Husemoen, L; Thorsted, BL; Webb, D; Khunti, K; Paul, SKJournal Article
17-Oct-2018Meta-analysis of the influence of lifestyle changes for preoperative weight loss on surgical outcomes.Roman, M; Monaghan, A; Serraino, GF; Miller, D; Pathak, S; Lai, F; Zaccardi, F; Ghanchi, A; Khunti, K; Davies, MJ; Murphy, GJJournal Article
25-Oct-2018Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysisMorrison, AE; Zaccardi, F; Khunti, K; Davies, MJJournal Article
7-Jan-2019Reply to Mantovani: "Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes"Zaccardi, F; Morrison, AE; Khunti, K; Davies, MJJournal Article
15-Dec-2016Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysisHtike, ZZ; Zaccardi, F; Papamargaritis, D; Webb, DR; Khunti, K; Davies, MJJournal Article
2-Apr-2019Temporal variation of renal function in people with type 2 diabetes mellitus: a retrospective UK Clinical Practice Research Datalink cohort study.Spanopoulos, D; Okhai, H; Zaccardi, F; Tebboth, A; Barrett, B; Busse, M; Webb, J; Khunti, KJournal Article